HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schlötzer-Schrehardt, U. Articles by Nüsing, R. M. Search for Related Content PubMed PubMed Citation Articles by Schlötzer-Schrehardt, U. Articles by Nüsing, R. M.

Expression and Localization of FP and EP Prostanoid Receptor Subtypes in Human Ocular Tissues

¹ From the Department of Ophthalmology, University of Erlangen-Nürnberg, Erlangen, Germany; and the ² Department of Pediatrics, Philipps University, Marburg, Germany.

PURPOSE. To determine the expression and precise cellular and subcellular localization of the EP prostanoid receptor subtypes EP₁ through EP₄ and the FP receptor in normal human ocular tissues on the protein and mRNA levels.

METHODS. Expression of EP and FP receptor proteins was examined by immunohistochemistry on the light microscopic level, using subtype-specific antibodies on frozen and paraffin-embedded tissue sections of 10 normal human donor eyes. The subcellular distribution of the receptor proteins was studied by electron microscopic immunogold labeling. mRNA expression in various ocular tissues was analyzed by reverse transcription-polymerase chain reaction, using subtype-specific primers.

RESULTS. The highest expression of the EP₁ receptor protein was found in the epithelia of the cornea, conjunctiva, lens, and the ciliary body; trabecular cells; iris vessels; and retinal ganglion cells. EP₂ receptor labeling was most prominent in the corneal epithelium and choriocapillaries. EP₃ and EP₄ receptor labeling was primarily observed in the corneal endothelium and keratocytes, trabecular cells, ciliary epithelium, and conjunctival and iridal stroma cells, and EP₃ was found, in addition, in retinal Müller cells. The highest expression of FP receptor protein was found in the corneal epithelium, ciliary epithelium, the circular portion of ciliary muscle, and iris stromal and smooth muscle cells. Immunoelectron microscopy showed a subcellular distribution of all prostanoid receptors along plasma membranes and the nuclear envelope. EP and FP receptor mRNA expression largely paralleled the proteins’ expression patterns.

CONCLUSIONS. The findings demonstrate a wide distribution but differential expression of FP and EP prostanoid receptor subtypes in human ocular tissues. EP₁ through EP₄ receptor subtype expression in human outflow pathways could be significant for future pharmacologic management strategies for the glaucomas.

This article has been cited by other articles:

				A. P. Joy and E. A. Cowley 8-iso-PGE2 Stimulates Anion Efflux from Airway Epithelial Cells via the EP4 Prostanoid Receptor Am. J. Respir. Cell Mol. Biol., February 1, 2008; 38(2): 143 - 152. [Abstract] [Full Text] [PDF]

				M. Zenkel, F. E. Kruse, G. O. H. Naumann, and U. Schlotzer-Schrehardt Impaired Cytoprotective Mechanisms in Eyes with Pseudoexfoliation Syndrome/Glaucoma Invest. Ophthalmol. Vis. Sci., December 1, 2007; 48(12): 5558 - 5566. [Abstract] [Full Text] [PDF]

				S. F. E. Nilsson, E. Drecoll, E. Lutjen-Drecoll, C. B. Toris, A. H.-P. Krauss, A. Kharlamb, A. Nieves, T. Guerra, and D. F. Woodward The Prostanoid EP2 Receptor Agonist Butaprost Increases Uveoscleral Outflow in the Cynomolgus Monkey. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 4042 - 4049. [Abstract] [Full Text] [PDF]

				T. Ota, M. Aihara, T. Saeki, S. Narumiya, and M. Araie The Effects of Prostaglandin Analogues on Prostanoid EP1, EP2, and EP3 Receptor-Deficient Mice. Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3395 - 3399. [Abstract] [Full Text] [PDF]

				M. Zenkel, F. E. Kruse, A. G. Junemann, G. O. H. Naumann, and U. Schlotzer-Schrehardt Clusterin Deficiency in Eyes with Pseudoexfoliation Syndrome May Be Implicated in the Aggregation and Deposition of Pseudoexfoliative Material Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1982 - 1990. [Abstract] [Full Text] [PDF]

				T. Schmitz, B. A Levine, and P. W Nathanielsz Localization and steroid regulation of prostaglandin E2 receptor protein expression in ovine cervix. Reproduction, April 1, 2006; 131(4): 743 - 750. [Abstract] [Full Text] [PDF]

				M. Watanabe, M. Noda, and S. Nakajin Effect of epidermal growth factor and prostaglandin on the expression of aromatase (CYP19) in human adrenocortical carcinoma cell line NCI-H295R cells J. Endocrinol., January 1, 2006; 188(1): 59 - 68. [Abstract] [Full Text] [PDF]

				U. Schlotzer-Schrehardt, M. Zenkel, U. Decking, D. Haubs, F. E. Kruse, A. Junemann, M. Coca-Prados, and G. O. H. Naumann Selective Upregulation of the A3 Adenosine Receptor in Eyes with Pseudoexfoliation Syndrome and Glaucoma Invest. Ophthalmol. Vis. Sci., June 1, 2005; 46(6): 2023 - 2034. [Abstract] [Full Text] [PDF]

				Y. Liang, C. Li, V. M. Guzman, A. J. Evinger III, C. E. Protzman, A. H.-P. Krauss, and D. F. Woodward Comparison of Prostaglandin F2{alpha}, Bimatoprost (Prostamide), and Butaprost (EP2 Agonist) on Cyr61 and Connective Tissue Growth Factor Gene Expression J. Biol. Chem., July 11, 2003; 278(29): 27267 - 27277. [Abstract] [Full Text] [PDF]